3,032 followers
New Research: Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study: The appropriate use of regulatory agilities has the potential to accelerate… https://t.co/P0fFIt595Z #medicalcare #cl